Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma

BACKGROUND: Lenalidomide is an active immunomodulatory and antiproliferative agent in multiple myeloma. However, the molecular mechanisms driving these activities are not yet fully elucidated. Therefore, we investigated the modulation of the cytokine/growth factor patterns of myeloma cells under LEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Maïga, S, Gomez-Bougie, P, Bonnaud, S, Gratas, C, Moreau, P, Le Gouill, S, Pellat-Deceunynck, C, Amiot, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658519/
https://www.ncbi.nlm.nih.gov/pubmed/23632478
http://dx.doi.org/10.1038/bjc.2013.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658519/
https://www.ncbi.nlm.nih.gov/pubmed/23632478
http://dx.doi.org/10.1038/bjc.2013.186

Ejemplares similares